中文 
别名:Cysteine-rich PAK1 inhibitor, CRIPak, CRIPAK应用:WB
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Negative regulator of PAK1. It has been suggested that the lost of CRIPAK in breast tumors might contribute to hormonal independence. |
| Specification | |
|---|---|
| Aliases | Cysteine-rich PAK1 inhibitor, CRIPak, CRIPAK |
| Swissprot | Q8N1N5 |
| WB Predicted band size | 48.1kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This CRIPAK antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 134-165 amino acids from the Central region of human CRIPAK. |
| Application | |
|---|---|
| WB | 1/1000 |
 |
All lanes : Anti-CRIPAK Antibody (Center) at 1:1000 dilution Lane 1: DU145 whole cell lysate Lysates/proteins at 20 µg per lane. Secondary Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ASP1615) at 1/15000 dilution. Observed band size : 48kDa Blocking/Dilution buffer: 5% NFDM/TBST. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复